P3 Health Partners Inc.
PIII
$2.74
-$0.34-11.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.25% | -4.66% | -6.16% | -3.93% | 2.01% |
| Total Other Revenue | 78.61% | -- | -- | -- | -- |
| Total Revenue | 3.81% | -4.66% | -6.16% | -3.93% | 6.87% |
| Cost of Revenue | 3.86% | -7.99% | -3.78% | -2.62% | 11.57% |
| Gross Profit | -4.31% | 38.35% | -68.27% | -81.62% | -89.92% |
| SG&A Expenses | 41.31% | -18.14% | -13.24% | -9.17% | 1.89% |
| Depreciation & Amortization | -0.75% | -2.95% | -2.81% | -2.26% | -2.22% |
| Other Operating Expenses | 46.11% | -230.65% | -75.65% | -796.20% | 1,234.18% |
| Total Operating Expenses | 8.84% | -16.98% | -5.01% | -4.86% | 20.39% |
| Operating Income | -23.84% | 58.67% | -8.90% | 13.10% | -93.35% |
| Income Before Tax | -34.27% | 34.76% | -49.91% | 9.17% | -84.43% |
| Income Tax Expenses | -121.00% | 100.31% | 104.65% | -48.21% | 180.25% |
| Earnings from Continuing Operations | -28.31% | 32.46% | -51.75% | 10.81% | -86.88% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 27.88% | -32.77% | 39.09% | -23.10% | 61.60% |
| Net Income | -28.83% | 32.09% | -69.40% | -9.52% | -130.21% |
| EBIT | -23.84% | 58.67% | -8.90% | 13.10% | -93.35% |
| EBITDA | -28.89% | 72.82% | -35.27% | 23.58% | -141.85% |
| EPS Basic | 8.44% | 32.71% | -41.66% | 20.11% | -127.68% |
| Normalized Basic EPS | -52.87% | 46.24% | -267.99% | -295.99% | -511.05% |
| EPS Diluted | -58.52% | 38.40% | 15.44% | 20.11% | 3.09% |
| Normalized Diluted EPS | -122.54% | 45.31% | -280.13% | -295.99% | -511.05% |
| Average Basic Shares Outstanding | 40.71% | 0.93% | 19.58% | 37.09% | 1.11% |
| Average Diluted Shares Outstanding | 349.48% | -0.79% | 15.77% | 37.09% | 1.11% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |